Seeing Is Believing
Currently out of the existing stock ratings of Edward White, 408 are a BUY (94.23%), 23 are a HOLD (5.31%), 2 are a SELL (0.46%).
Analyst Edward White, carries an average stock price target met ratio of 31.83% that have a potential upside of 53.91% achieved within 138 days. Previously, Edward White worked at HC WAINWRIGHT.
Edward White’s has documented 817 price targets and ratings displayed on 39 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CGEM, Cullinan Oncology LLC at 16-Apr-2025.
Analyst best performing recommendations are on SBTX (SILVERBACK THERAPEUTICS ).
The best stock recommendation documented was for MRTX (MIRATI THER) at 11/15/2017. The price target of $17 was fulfilled within 1 day with a profit of $2.95 (21%) receiving and performance score of 209.96.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 24-Oct-2024
$4.25
$-0.09 (-2.07%)
$4.25
1 years 4 months 4 days ago
(08-Nov-2024)
1/5 (20%)
$-0.11 (-2.52%)
148
Buy Since 20-Jul-2022
1 years 7 months 10 days ago
(02-Aug-2024)
0/1 (0%)
$12.65 (172.11%)
Buy Since 02-Dec-2020
$10
$5.66 (130.41%)
$10
2 years 6 months 18 days ago
(22-Aug-2023)
1/4 (25%)
$7.03 (236.70%)
28
Hold Since 14-Nov-2022
$7
$2.66 (61.29%)
3 years 3 months 4 days ago
(08-Dec-2022)
2/3 (66.67%)
$2.8 (66.67%)
79
Buy Since 01-May-2020
$26
3 years 3 months 26 days ago
(14-Nov-2022)
2/5 (40%)
$17.95 (222.98%)
182
What Year was the first public recommendation made by Edward White?